Ownership history in MITCHELL SINKLER & STARR/PA Β· 52 quarters on record
This page tracks every 13F SEC filing in which MITCHELL SINKLER & STARR/PA reported a position in ABBVIE INC COMMON STOCK (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π MITCHELL SINKLER & STARR/PA outperformed the S&P 500 by +6.4% annually on this ABBV position. Timing score: 44% (19/43 decisions correct). Average cost basis: $134.36. Maximum drawdown during holding period: β20.3%.
π₯ Exceptional β beat the S&P 500 by 6.4% per year on this position.
50 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
19 of 43 add/trim decisions correct
Best entry: $24.92 (2013 Q2) Β· Worst: $226.67 (2025 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
15 adds Β· 30 trims. Bought during 6 of 20 down-price quarters. π Predominantly trimming β distribution phase.
π MITCHELL SINKLER & STARR/PA has been actively increasing its ABBV allocation β a bullish signal from insiders.
Currently 1.42% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size